GlassScriptPhysician profile
Madison A Fish
NPI 1760879431
$1,147.89
in general payments reported to CMS, 2019-2025
22 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.53 · 2022: $517 · 2023: $200 · 2024: $200 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $200.96 | 2021-2024 | Lo Loestrin Fe, Liletta, Orilissa |
| Mayne Pharma Commercial LLC | $174.67 | 2022-2025 | |
| Myovant Sciences INC. | $157.94 | 2021-2022 | |
| Hologic Sales and Service, LLC | $103.18 | 2024-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Coopersurgical, INC. | $44.68 | 2022-2024 | Paragard T 380a |
| Organon LLC | $44.41 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $41.29 | 2023-2025 | |
| Biogen, INC. | $40.62 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $40.04 | 2022-2024 | |
| Therapeuticsmd, INC. | $33.47 | 2021-2022 | |
| Pfizer INC. | $31.79 | 2023 | |
| Becton, Dickinson and Company | $31.43 | 2023 | Bd Affirm Vpiii Microbial Identification Test |
| Baxter Healthcare | $30.17 | 2022 | |
| Sumitomo Pharma America, INC. | $29.75 | 2023 | Myfembree |
| Astellas Pharma US INC | $28.71 | 2024 | Veozah |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $24.15 | 2024 | Intrarosa, Femring |
| Daiichi Sankyo INC. | $19.38 | 2022 | |
| Exeltis, USA INC. | $16.35 | 2022 | |
| Aspira Women'S Health INC | $16.07 | 2022 | |
| Abbott Laboratories | $15.85 | 2022 | |
| Avion Pharmaceuticals | $14.52 | 2022 | |
| Channel Medsystems, INC. | $8.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Fish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.